Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Staevska

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Cough (London, England)|March 22, 2014
A real - life observational pilot study to evaluate the effects of two-week treatment with montelukast in patients with chronic coughRoxana K Mincheva, Tanya Z Kralimarkova, Miroslava Rasheva, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 22, 2014
Objective approach for fending off the sublingual immunotherapy placebo effect in subjects with pollenosis: double-blinded, placebo-controlled trialTanya Z Kralimarkova, Todor A Popov, Maria Staevska, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|January 22, 2020
A novel deep intronic SERPING1 variant as a cause of hereditary angioedema due to C1-inhibitor deficiencySofia Vatsiou, Maria Zamanakou, Gedeon Loules, et al.
Frontiers in Allergy|July 25, 2022
Searching for Genetic Biomarkers for Hereditary Angioedema Due to C1-Inhibitor Deficiency (C1-INH-HAE)Faidra Parsopoulou, Gedeon Loules, Maria Zamanakou, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 23, 2019
Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedemaAnna Valerieva, Maria Staevska, Milos Jesenak, et al.
Gene|May 14, 2018
Targeted next-generation sequencing for the molecular diagnosis of hereditary angioedema due to C1-inhibitor deficiencyGedeon Loules, Maria Zamanakou, Faidra Parsopoulou, et al.
The Lancet. Respiratory Medicine|February 13, 2025
Effect of dupilumab on exhaled nitric oxide, mucus plugs, and functional respiratory imaging in patients with type 2 asthma (VESTIGE): a randomised, double-blind, placebo-controlled, phase 4 trialMario Castro, Alberto Papi, Celeste Porsbjerg, et al.
The New England Journal of Medicine|May 31, 2024
Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema AttacksMarc A Riedl, Henriette Farkas, Emel Aygören-Pürsün, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 31, 2025
Long-term Safety and Effectiveness of Sebetralstat: Interim Analysis of KONFIDENT-S Open-label ExtensionHenriette Farkas, John Anderson, Laurence Bouillet, et al.
The World Allergy Organization Journal|June 19, 2026
Sebetralstat for on-demand treatment of hereditary angioedema: A pooled analysis of placebo-controlled clinical trialsEmel Aygören-Pürsün, Danny M Cohn, Nancy Agmon-Levin, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Cough (London, England)|March 22, 2014
A real - life observational pilot study to evaluate the effects of two-week treatment with montelukast in patients with chronic coughRoxana K Mincheva, Tanya Z Kralimarkova, Miroslava Rasheva, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|April 22, 2014
Objective approach for fending off the sublingual immunotherapy placebo effect in subjects with pollenosis: double-blinded, placebo-controlled trialTanya Z Kralimarkova, Todor A Popov, Maria Staevska, et al.
Allergology International : Official Journal of the Japanese Society of Allergology|January 22, 2020
A novel deep intronic SERPING1 variant as a cause of hereditary angioedema due to C1-inhibitor deficiencySofia Vatsiou, Maria Zamanakou, Gedeon Loules, et al.
Frontiers in Allergy|July 25, 2022
Searching for Genetic Biomarkers for Hereditary Angioedema Due to C1-Inhibitor Deficiency (C1-INH-HAE)Faidra Parsopoulou, Gedeon Loules, Maria Zamanakou, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 23, 2019
Recombinant human C1 esterase inhibitor as short-term prophylaxis in patients with hereditary angioedemaAnna Valerieva, Maria Staevska, Milos Jesenak, et al.
Gene|May 14, 2018
Targeted next-generation sequencing for the molecular diagnosis of hereditary angioedema due to C1-inhibitor deficiencyGedeon Loules, Maria Zamanakou, Faidra Parsopoulou, et al.
The Lancet. Respiratory Medicine|February 13, 2025
Effect of dupilumab on exhaled nitric oxide, mucus plugs, and functional respiratory imaging in patients with type 2 asthma (VESTIGE): a randomised, double-blind, placebo-controlled, phase 4 trialMario Castro, Alberto Papi, Celeste Porsbjerg, et al.
The New England Journal of Medicine|May 31, 2024
Oral Sebetralstat for On-Demand Treatment of Hereditary Angioedema AttacksMarc A Riedl, Henriette Farkas, Emel Aygören-Pürsün, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 31, 2025
Long-term Safety and Effectiveness of Sebetralstat: Interim Analysis of KONFIDENT-S Open-label ExtensionHenriette Farkas, John Anderson, Laurence Bouillet, et al.
The World Allergy Organization Journal|June 19, 2026
Sebetralstat for on-demand treatment of hereditary angioedema: A pooled analysis of placebo-controlled clinical trialsEmel Aygören-Pürsün, Danny M Cohn, Nancy Agmon-Levin, et al.
Pageof 3